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Objective 
We set out to assess the feasibility, reliability and sensitivity to change of four 
radiographic scoring methods in psoriatic arthritis (PsA). 
Methods 
Hand and feet radiographs from fifty patients with PsA were scored at two time points 
with each of the modified Steinbrocker score (STB), modified Sharp score (MSS), 
Sharp-van der Heijde modified method (VDH) and psoriatic arthritis Ratingen score 
(PARS) methods by two assessors. The radiographs of ten patients were scored by 
both assessors to assess reliability using intra-class correlation coefficients (ICC). 
Sensitivity to change was estimated using a Standardised Response Mean (SRM) and 
Smallest Detectable Change (SDC). 
Results 
The patients’ mean age at baseline was 50 years (sd 12.1), mean disease duration 10 
years (sd 8.4) and mean follow up 25 months (sd 9.6). Intra-rater reliability was 
excellent for all methods (ICC >0.97). Inter-rater reliability was highest for the VDH 
(ICC 0.95 to 0.99). The  percentage smallest detectable change (SDC) for the STB, 
PARS, MSS and VDH methods was 2.9%, 2.1%, 1.4% and 1.2%, respectively and the 
SRMs were 0.46, 0.44, 0.77 and 0.79 respectively. The mean time to score each of the 
STB, PARS, MSS and VDH methods was 6.2, 10.5, 14.6 and 14.4 minutes, 
respectively. 
Conclusions 
The VDH method was the most reliable and sensitive to change but took longer to 
perform. The STB is the most feasible but lacks the sensitivity of the VDH. The SDC 
of the PARS is close to that of the VDH and MSS but is quicker to perform. 
  
Significance and Innovations 
 
 Longitudinal observational studies of psoriatic arthritis rarely report 
radiographic data, in part due to the perceived, but not proven, unfeasibility of 
existing scores. 
 
 We report the first comparison of feasibility, reliability and sensitivity to 
change of four radiographic scoring methods for psoriatic arthritis in an 
observational cohort.  
 
 We have shown that none of the existing radiographic measures are both 
sufficiently feasible and sensitive to change to be easily applied in large 
longitudinal observational studies. 
 
 This study highlights the need for existing scores to be modified to a tool that 
encourages use and prompts collaboration by the psoriatic arthritis research 
community.  
The measurement of radiographic joint damage is essential in characterising disease 
severity, progression and prognosis. Radiographic damage has been demonstrated in 
psoriatic arthritis in both early and established disease [1, 2]. It is a core outcome 
measure in both randomised control trials for novel therapies as well as longitudinal 
observational studies and is included in the research agenda as a domain of interest by 
the Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) 
consortium [3]. 
 
Several scoring methods have been proposed for use in psoriatic arthritis including the 
Modified Sharp score (MSS)[4, 5], the Sharp-van der Heijde modified method 
(VDH)[5, 6], Modified Steinbrocker (STB)[7] and psoriatic arthritis Ratingen score 
(PARS)[8]. With the exception of the Ratingen method these scoring methods were 
designed and validated for use in rheumatoid arthritis and subsequently modified for 
use in psoriatic arthritis. 
 
The choice of radiographic outcome measure to use in psoriatic arthritis randomised 
controlled trials and longitudinal observational studies was discussed at the Group for 
Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) annual 
meeting 2012 in Stockholm. There was consensus that the Sharp-van der Heijde was 
the optimal tool to use in randomised controlled trails (where sensitivity to change is 
often the most important attribute of the outcome measure) but the most appropriate 
tool for use in longitudinal observational studies is yet to be determined. Agreement 
on the use of a single measure in such observational studies would improve 
comparison of results between cohorts, pooling data and potentially aid meta-
analyses. We set out to assess the feasibility, reliability and sensitivity to change of 
four radiographic scoring methods in psoriatic arthritis in order to inform discussion 
on the optimal method for longitudinal observational studies. 
 
Materials and Methods 
Postero-anterior radiographs of the hands and feet from fifty consecutive patients 
commenced on anti-Tumour Necrosis Factor (anti-TNF) therapy for psoriatic arthritis 
at the Royal National Hospital for Rheumatic Diseases were included. Radiographs 
taken at the point of anti-TNF commencement and two years prior were scored with 
each of the modified Steinbrocker score, modified Sharp score, Sharp-van der Heijde 
method and Ratingen methods. This selection of participants and radiographs was 
designed to capture patients likely to have sustained active disease and thus 
progression of radiographic damage upon which the sensitivity to change of each 
method could be compared. All radiographs included a ‘phantom phalanx’ as a 
reference for normal bone density. All selected patient’s fulfilled the Classification 
Criteria for Psoriatic Arthritis (CASPAR) criteria after retrospective assessment of 
case records[9] [10]. 
 
Radiographic scoring methods 
Standard antero-posterior radiographs of the hands and forefeet were taken on to 
Kodak DirectView phosphor storage plates. Directly after the images were captured 
the phosphor plates were scanned and digitised using the Kodak DirectView CR 950 
system. Images were then viewed and scored on the Centricity Web viewer (V3.0.10) 
on a standard Hewlett Packard monitor (1440-900 pixel spacing) with the images 
preserved at the original 1:1 ratio, all other viewing tools were allowed.  
 
The radiographic techniques are described briefly below and summarised in Table 1. 
The Steinbrocker is a global technique that scores the joints of the hands and feet for 
soft tissue swelling or periarticular osteopenia, erosion, joint space narrowing, total 
destruction (lysis or ankylosis) on a single scale. The Steinbrocker was originally 
developed for use in rheumatoid arthritis and was modified for use in psoriatic 
arthritis through inclusion of the distal interphalangeal (DIP) joints.[7] The Sharp-van 
der Heijde and modified Sharp scores are composite methods that score erosion and 
joint space narrowing separately and then are summed together in a total score. The 
Sharp-van der Heijde method was originally developed for use in rheumatoid arthritis 
then modified for use in psoriatic arhritis [5, 6].  The modified Sharp score was again 
adapted from the original method used in rheumatoid arthritis [4]. The method we 
have used in this study is the same as that described by Ravindran et al. with the 
addition that we have included the feet as originally described by van der Heijde [1, 
11]. Finally the psoriatic arthritis Ratingen score is the only method to be developed 
specifically for use in psoriatic arthritis [8]. This composite method scores erosion 
and bony proliferation characteristic for psoriatic arthritis which are then summed in a 
total score.  
 
Reading strategy 
Two readers, WT and DJ trained in the four scoring methods. This process involved 
pre-study training in the precise definitions of radiographic findings of psoriatic 
arthritis as described by Taylor et al. [12], literature review of each method, contact 
with the original authors for clarification where required, then practice with 
supervision and discussion with an experienced musculoskeletal radiologist (GR) over 
a two month period. To determine reliability, ten sets of hand and feet radiographs 
were scored by both WT and DJ with all four techniques in random order to assess 
inter-rater reliability, and then scored one month later to estimate intra-rater 
reliability. The remaining 40 radiographs were then scored (20 by WT and 20 by DJ) 
with the prior score and radiographs available to optimise sensitivity to change. An 
assumption of progression only was made for all scores, thus no improvement was 
recorded.  
 
Statistical analysis 
Demographic data was analysed using descriptive statistics. Feasibility was estimated 
using the average time taken to score each method. Measurement error was estimated 
by re-scoring ten films by the same rater (intra-rater reliability) and by the other rater 
(inter-rater reliability). Differences are reported as recommended using both intra-
class correlation coefficients (ICC) and visually by plotting the difference in change 
of scores against the mean change by both raters (Bland-Altman plots) [13]. 
 
Sensitivity to change is reported using multiple methods to allow comparison with 
prior reports. A two-way analysis of variance was performed with an interaction 
between patient and time leaving a residual from which the standard error of the mean 
could be estimated. The standardised response mean (SRM) is a unit-less expression 
of change calculated as the ratio of the mean difference between baseline and follow 
up score divided by the standard deviation of this difference. A standardised response 
mean of >0.8 is considered to have a high potential of detecting change. We also 
report the Smallest Detectable Change (SDC) defined as the smallest difference that 
can be detected over and above measurement error [14]. A similar method of 
reporting this is the Smallest Detectable Difference (SDD). The smallest detectable 
difference is a less appropriate method to use in this study because we have assessed 
radiographs with the prior film and score available meaning the assessments cannot be 
considered to be truly independent. In this instance the smallest detectable difference 
will overestimate the measurement error, however, we have reported this estimate to 
allow for comparison with prior reports. We also report both the smallest detectable 
change and smallest detectable difference a percentage of the total score to allow 
comparison between methods. 
 
The study was approved by the Bath Research Ethics Committee and has been 
conducted in accordance with the Declaration of Helsinki. All participants signed 
informed consent.  
  
Results 
All patients fulfilled CASPAR criteria for psoriatic arthritis. The mean age of patients 
at the baseline assessment was 50 years (sd 12.1; median 53 years, range 49). The 
mean disease duration at baseline was 10 years (sd 8.4; median 8 years, range 29). 
The mean interval between radiographs was 25 months (sd 9.6; median 26 months, 
range 36). The mean baseline score for the Steinbrocker, Ratingen, modified Sharp 
and Sharp-van der Heijde was 15.4 (sd 21.63), 13.2 (sd 25.23), 26.3 (sd 39.05) and 
26.8 (sd 38.25).  
 
The intra-rater reliability was high for all methods (Table 2). The baseline inter-rater 
reliability was high for the Sharp-van der Heijde, modified Sharp and Ratingen scores 
at 0.95 95% confidence interval (CI) 0.83-0.99, 0.94 (95% CI 0.78-0.96) and 0.89 
(95% CI 0.64-0.97), respectively. The baseline inter-rater reliability for the 
Steinbrocker was low at 0.42 (95% CI -0.21-0.81). Review of the 10 films revealed 
the source to be poor agreement on the presence of periarticular osteopenia in three of 
the ten cases. All 50 baseline radiographs were therefore scored using the 
Steinbrocker by both readers to better reflect the frequency of osteopenia in PsA and 
hence more accurately estimate the performance of the Steinbrocker. The baseline 
inter-rater reliability for all 50 radiographs was 0.88 (95% CI 0.77-0.94). 
 
The sensitivity to change of the methods is reported in Table 3. Using the smallest 
detectable change expressed as a percentage of the total score allows comparison 
between scores. The Sharp-van der Heijde has the greatest ability to detect change 
followed by the modified Sharp, Ratingen and Steinbrocker at 1.2%, 1.4%, 2.1% and 
2.9% respectively. The sensitivity to change of the methods using the standardised 
response mean demonstrated the Sharp-van der Heijde followed by the modified 
Sharp score to have the greatest ability to detect change at a level approaching 0.80. 
The Steinbrocker and Ratingen scores showed less sensitivity to change with levels of 
0.46 and 0.44 respectively. 
 
The feasibility of each method was estimated based on the mean time taken to score 
each film. The Steinbrocker took the least time to score followed by the Ratingen, 
Sharp-van der Heijde and modified Sharp at 6.2 minutes, 10.5 minutes, 14.4 minutes 
and 14.6 minutes respectively.  
 
  
Discussion 
Radiographic assessment of joint damage in psoriatic arthritis is an important 
outcome measure in longitudinal observational studies however the optimal method 
for use in this setting has not been determined and to our knowledge there are no 
reports comparing the existing methods. We report a comparison of four radiographic 
scoring methods used in psoriatic arthritis to inform discussion on the optimal method 
for use in longitudinal observational studies.  
 
In terms of feasibility each of these methods are readily available and interpretable as 
a simple summative score. The time required to apply each method differs 
considerably in our study from 6.2 minutes to 14.6 minutes. An essential attribute of a 
scoring method for use in longitudinal observational studies is that it can be readily 
learned and applied feasibly. This ‘feasibility barrier’ has resulted in very limited 
radiographic data collection from observational cohorts. As may be expected, the 
global score (the Steinbrocker) is the most feasible and the time required to apply the 
composite scores is proportional to the number of areas scored (Ratingen<Sharp-van 
der Heijde<modified Sharp). Whilst there is no threshold of time beyond which a 
score becomes unfeasible, the Sharp-van der Heijde and modified Sharp scores are 
more challenging in terms of time required for application in longitudinal 
observational studies. 
 
In our study we found good agreement between assessors and good test-re-test 
reliability. The exception was osteopenia in the Steinbrocker. The inter/intra-rater 
reliability estimates for this study (baseline inter 0.88 and intra for both readers 0.99/ 
1.0) are comparable with the original reports (inter 0.86 and intra for both readers 
0.81/ 0.80) [7]. We found the inter-rater reliability was poor (0.42) amongst the initial 
ten patients due to disagreement in three cases of possible osteopenia but rose to more 
acceptable levels (0.88) when applied to all 50 patients because less osteopenia was 
seen. The prevalence of periarticular osteopenia in psoriatic arthritis has not been 
reported but is thought to be less than rheumatoid arthritis[15]. Our group has 
previously reported a strong correlation between the modified Sharp score and 
periaticular osteopenia, present in 25 of the 73 psoriatic arthritis patient hand and feet 
radiographs included in the study[1]. Radiographic osteopenia is dependent on 
radiographic technique, varying according to choice of projection, exposure and 
capture media, thus may vary significantly between time-points and radiographers. 
Determining the presence of osteopenia is also subjective and therefore prone to 
variation. For these reasons osteopenia was removed from a number of radiographic 
scoring techniques in rheumatoid arthritis [16]. It may be argued therefore that any 
potential benefits of retaining osteopenia in a measure for use in longitudinal 
observational studies of psoriatic arthritis are outweighed by these disadvantages. 
 
Regarding sensitivity to change we found the smallest detectable change to be greater 
than the mean change over two years in all techniques which is an important finding. 
The minimal detectable change/ smallest detectable change/ difference are all study 
specific (a function of mean change and measurement error) but are infrequently 
reported in trials [17]. There are no previous reports directly comparing the sensitivity 
to change of the Steinbroker, Sharp-van der Heijde and modified Sharp scores in 
psoriatic arthritis. The original Ratingen score method reported a minimal detectable 
change (calculated from the square root of the standard deviation of the inter-rater 
variance) for the total score, proliferation score and destruction score of 16.5, 8.4 and 
11.5, respectively, which are comparable with our smallest detectable difference of 
12.7, 5.8 and 7.3, respectively[8]. Guillemin et al. examined the reproducibility and 
sensitivity to change of five methods including the Sharp-van der Heijde in 
rheumatoid arthritis [18].  The mean change in the Sharp-van der Heijde score 
exceeded the smallest detectable difference for the total, erosion and joint space 
narrowing scores in their study (9.7, 5.8 and 7.2, respectively) yet the smallest 
detectable difference remains comparable with our study (10.8 , 7.3 and 7.3, 
respectively). Sharp et al examined the variability of precision of the modified Sharp 
method among readers from the datasets of six studies in rheumatoid arthritis [19]. 
Considerable variability between readers and the mean smallest detectable difference 
was greater than the mean progression, as we have found in our present study.  We 
found that the smallest detectable difference/ change (normalised as a percentage of 
the total score to allow comparison) estimates were ranked as might be expected 
(Steinbrocker > Ratingen > modified Sharp > Sharp-van der Heijde). The smallest 
detectable difference/ change are largest for the global Steinbrocker score which 
assesses radiographic change as either present or absent rather than graded, thereby 
allowing less flexibility to detect change. The Sharp-van der Heijde is consistently the 
most sensitive to change than the score from which it was derived (the modified Sharp 
score). Finally the Ratingen score is more sensitive than the Steinbrocker as it is a 
composite rather than global score allowing grading of erosion and proliferation but 
not as sensitive as the Sharp-van der Heijde partly because it includes the wrist as a 
single joint rather than multiple small joints.  
 
Other parameters within the scoring methods are worth noting. The soft tissue 
swelling element of the Steinbrocker is an additional source of variability, particularly 
at the MTP joints there is a less clear view of the soft tissues. The scoring of joint 
space narrowing is not specific to psoriatic arthritis and can occur in concurrent 
osteoarthritis and thus over-estimate progression. The Ratingen score includes a 
measure of proliferation which was the only radiographic change sufficiently specific 
to psoriatic arthritis to justify inclusion in the CASPAR criteria [9]. Finally, the 
composite scores preserve data separately on erosion, joint space narrowing or in the 
case of the Ratingen score proliferation whereas such information is limited in a 
global score.  
 
The findings of this study should be interpreted in light of certain methodological 
limitations. We have not blinded to the order of films and have both films available 
for comparison when scoring introducing the possibility of expectation bias and thus 
overestimating change. However, blinding to films may result in failure to detect 
progression. A study in rheumatoid arthritis has shown that blinding assessors to the 
chronology of films can introduce a measurement error that results in a loss of signal 
and hence underestimation of progression[20]. A second study from the same group 
showed that expert raters agreed most when the sequence of films was known[21]. 
Furthermore, two of the methods, the Ratingen score and Sharp-van der Heijde scores 
were both developed in un-blinded studies with known chronological order and so we 
have applied these tools as they were developed. We have selected patients with 
established disease in the two years prior to anti-TNF therapy and therefore likely to 
have progressive disease in order to study and compare the sensitivity to change of 
each method. The exact chronology of radiographic change in psoriatic arthritis is not 
yet established and therefore it is possible the scores may perform differently in early 
disease. Finally this study is informing the measurement of radiographic outcome in 
observational studies where radiographs are most likely to be scored in known order 
and unblinded. A final potential limitation is that we have scored the radiographs with 
the assumption of no improvement as stipulated in the Sharp-van der Heijde scoring 
instructions. We applied the same rule to all methods to avoid biasing the results. This 
may have had the effect of overestimating the standardised response mean of the 
Steinbrocker which includes soft tissue swelling which may well improve over the 
study period.  
 
We have found that the modified Sharp and Sharp-van der Heijde methods are the 
most reliable and sensitive to change in this present study, but took longer to perform.  
The Steinbrocker is the most feasible but lacks the sensitivity of the modified Sharp 
and Sharp-van der Heijde methods. The smallest detectable change of the Ratingen 
score is close to that of the modified Sharp and Sharp-van der Heijde but is quicker to 
perform and may be more specific to PsA through inclusion of proliferation. The 
findings of this study can be used to inform discussion on potential modifications and 
further study of these existing radiographic scoring methods for use in longitudinal 
observational studies of psoriatic arthritis. 
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Table 1. Summary of scoring methods  
 
Scoring 
methods 
Scales Total  
erosion  
score 
Total  
JSN 
score 
Total 
score 
STB 42 Joints of the hands and feet: Scale 0-4 
0 is normal. 
1 is juxta-articular osteopenia or soft tissue swelling. 
2 indicates the presence of any erosion. 
3 the presence of erosion and joint space narrowing. 
4 total joint destruction (lysis or ankylosis). 
 
N/A N/A 168 
MSS 54 joints (42 hands, 12 feet) for erosion: scale 0-5 
0 = no erosion. 
1 = one discrete erosion or involvement of < 21% of the joint are by erosion. 
2 = two discrete erosions or involvement of 21- 40% of the joint. 
3 = three discrete erosions or involvement of 41-60% of the joint. 
4 = four discrete erosions or involvement of 61-80% of the joint. 
5 = extensive destruction involving more than 80% of the joint. 
54 joints (44 hands, 10 feet) for JSN: scale 0-4 
0 = normal joint. 
1 = asymmetrical or minimal narrowing. 
2 = definite narrowing with loss of up to 50% for the normal space. 
3 = definite narrowing with loss of 51 – 99% of the normal space. 
4 = absence of a joint space, presumptive evidence of ankylosis. 
5 = widening. 
 
270 216 486 
VDH 52 joints (42 hands, 10 feet) for erosion: scale 0-5 (hands) 0-10 (feet) 
0 = no erosions. 
1= discrete erosion. 
2 = large erosion not passing the midline. 
3 = large erosion passing the mid-line. 
4 = combination of below 
5 = combination of below 
52 joints (42 hands, 10 feet) for JSN: scale 0-4 
0 = normal 
1 = asymmetrical minimal narrowing with loss of up to a maximum of 25% 
2 = definite narrowing with loss of up to 50% of the normal space 
3 = definite narrowing with loss of 50 – 99% of the normal space or subluxation 
4 = absence of a joint space, presumptive evidence of ankylosis, or complete 
subluxation. 
 
320 208 528 
PARS 40 joints (30 hands, 10 feet) for destruction: scale 0-5 
0 = normal. 
1 = one or more definite erosion with an interruption of the cortical plate of >1mm but 
destruction of < 10% of the total joint surface. 
2 = destruction of 11 – 25%. 
3 = destruction of 26 – 50%. 
4 = destruction of 51 – 75% . 
5 = destruction of more than 75% of the joint surface. 
40 joints (30 hands, 10 feet) for proliferation: scale 0-4 
0 = normal. 
1 = bony proliferation measured from the original bone surface of 1-2mm, or clearly 
identifiable bone growth not exceeding 25% of the original diameter of the bone.  
2 = bony proliferation of 2-3mm or bone growth between 25 to 50%  
3 = bony proliferation >3mm or bone growth >50% 
4 = bony ankylosis. 
200 160 * 360 
 
 
Steinbrocker method (STB), Sharp van der Heijde method (VDH), Modified Sharp method (MSS), 
Ratingen method (PARS), Joint space narrowing (JSN) *Proliferation 
 Table 2. Inter/ Intra-rater reliability of each scoring method 
 
Method Range Inter rater reliability (95%CI) Intra rater reliability (95%CI) 
  Baseline Follow up Rater 1 Rater 2 
STB 
 STB (n=50) 
0-168 0.42 (-0.21-0.81) 
0.88 (0.77-0.94) 
0.40 (-0.23-0.81) 
 
0.99 (0.95-1.0) 
 
1.00 (0.99-1.00) 
MSS 
 Erosion 
 JSN 
0-486 
0-270 
0-216 
0.94 (0.78-0.96) 
0.77 (0.35-0.94) 
0.96 (0.86-0.99) 
0.96 (0.86-0.99) 
0.64 (0.10-0.90) 
0.94 (0.81-0.99) 
0.99 (0.95-1.00) 
0.77 (0.35-0.94) 
0.95 (0.81-0.99) 
1.00 (0.99-1.00) 
1.00 (0.99-1.00) 
0.99 (0.98-1.00) 
VDH 
 Erosion 
 JSN 
0-528 
0-320 
0-208 
0.95 (0.83-0.99) 
0.91 (0.70-0.98) 
0.96 (0.87-0.99) 
0.99 (0.96-1.00) 
0.92 (0.72-0.98) 
0.92 (0.73-0.98) 
0.97 (0.90-0.99) 
0.91 (0.69-0.98) 
0.93 (0.76-0.98) 
0.99 (0.98-0.99) 
1.00 (0.99-1.00) 
0.98 (0.97-0.99) 
PARS 
 Destruction 
 Proliferation 
0-360 
0-200 
0-160 
0.89 (0.64-0.97) 
0.69 (0.18-0.91) 
0.90 (0.67-0.97) 
0.90 (0.65-0.97) 
0.69 (0.18-0.91) 
0.85 (0.52-0.96) 
0.99 (0.95-1.00) 
0.76 (0.31-0.93) 
0.90 (0.66-0.97) 
0.99 (0.97-1.00) 
1.00 (0.99-1.00) 
1.00 (0.98-1.00) 
Modified Steinbrocker method (STB), Sharp-van der Heijde modified method (VDH), Modified Sharp 
method (MSS), psoriatic arthritis Ratingen score (PARS), Joint space narrowing (JSN) 
 
  
Table 3. Sensitivity to change of each scoring method 
 
Method Mean 
Change 
SD  
of change 
SEM SRM SDD SDC SDD 
as % of  
total 
score  
SDC  
as % of  
total 
score 
STB 2.3 4.91 3.49  0.46 8.11 4.83 4.82 2.87 
PARS 
 Destruction 
 Proliferation 
3.3    
1.6   
 1.8   
7.61 
3.46 
4.28 
5.46 
2.51 
3.15  
0.44 
0.45 
0.43 
12.71  
5.83 
7.34 
7.57  
3.48  
4.37 
3.53 2.10 
MSS 
 Erosion 
 JSN 
5.5   
 2.4    
3.3    
7.15 
4.15 
5.10 
5.06 
2.97 
3.64  
0.77 
0.57 
0.64 
11.77   
6.90 
8.47 
7.01 
4.11 
5.05 
2.42 1.44 
VDH 
 Erosion 
 JSN 
5.2  
  2.3 
  3.0    
6.53 
4.41 
4.36 
4.66 
3.14 
3.14  
0.79 
0.52 
0.68 
10.83   
7.31 
7.29 
6.45 
4.36 
4.35 
2.05 1.22 
Modified Steinbrocker method (STB), Sharp-van der Heijde modified method (VDH), Modified Sharp 
method (MSS), psoriatic arthritis Ratingen score (PARS), Joint space narrowing (JSN), Standard 
deviation (SD), Standard error of means (SEM), Standardised response mean (SRM), Smallest 
detectable difference (SDD), Smallest detectable change (SDC). 
 
  
